Injectable Antibodies: Products, Markets, Players and Forecasts

153 views

Published on

The administration of therapeutic antibodies via injection is becoming an increasingly important healthcare treatment method for a growing number diseases and indications having broad implications for patient health and well-being. The inherent instability of protein drugs has led to a number of challenges as the developers of injectable antibodies attempt to deal with packaging, handling, reconstitution and drug administration issues. These challenges are being compounded by the trend to patient self-medication, as population demographics and efforts by managed care providers to control healthcare costs drive the growth in drug self-administration, particularly for chronic conditions. This trend is introducing a new class of na

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
153
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Injectable Antibodies: Products, Markets, Players and Forecasts

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Injectable Antibodies: Products, Markets, Players and ForecastsPublished on May 2012 Report SummaryThe administration of therapeutic antibodies via injection is becoming an increasingly important healthcare treatment method for agrowing number diseases and indications having broad implications for patient health and well-being. The inherent instability ofprotein drugs has led to a number of challenges as the developers of injectable antibodies attempt to deal with packaging, handling,reconstitution and drug administration issues. These challenges are being compounded by the trend to patient self-medication, aspopulation demographics and efforts by managed care providers to control healthcare costs drive the growth in drugself-administration, particularly for chronic conditions. This trend is introducing a new class of naïve users to parenteral drug delivery.This report analyzes twenty-six injectable/Infusible therapeutic antibody drugs and examines key packaging, dosing, regulatory,economic and competitive factors that represent opportunities, risk factors and potential barriers to commercial success.Highlights· Provides detailed analysis of injectable antibody market segments, market dynamics and market demographics· Analyzes products, therapeutic demand drivers and evaluates commercial drug products in more than two dozen injectableantibodies· Analyzes technologies and market development issues for injectable antibodies· Provides market data and forecasts to 2016· Profiles market participants, their product development activities, business strategies, and corporate alliances and affiliations Table of ContentSummary of ContentsExecutive SummaryAntibody Therapeutics Market DynamicsThe Antibody Therapeutics MarketspaceClinical Trials and Drug ApprovalsThe Competitive LandscapeDemographics, Managed Care and GrowthRisks and OpportunitiesFormulating Antibody DrugsFormulation StrategiesAntibody Formulation TechnologiesInjectable Antibodies: Products, Markets, Players and Forecasts (From Slideshare) Page 1/5
  2. 2. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Antibody Packaging & DeliveryAntibody Drug Distribution StrategiesInjectable Antibodies Indications and Therapeutic MarketsAsthmaInfectious DiseaseOncologyAutoimmunityOsteoporosisMacular DegenerationInjectable Antibody Drug Product Assessments and ForecastsAdalimumab (Humira)Alefacept (Amevive)Alemtuzumab (Campath)Belimumab (Benlysta)Bevacizumab (Avastin)Brentuximab vedotin (Adcetris)Canakinumab (Ilaris)Certolizumab (Cimzia)Cetuximab (Erbitux)Denosumab (Prolia)Eculizumab (Soliris)Gemtuzumab (Mylotarg)Golimumab (Simponi)Ibritumomab (Zevalin)Infliximab (Remicade)Natalizumab (Tysabri)Ofatumumab (Arzerra)Palivizumab (Synagis)Panitumumab (Vectibix)Omalizumab (Zolair)Ranibizumab (Lucentis)Rituximab (Rituxin)Tocilizumab (Actemra)Tositumomab (Bexxar)Trastuzumab (Herceptin)Ustekinumab (Stelara)Market FactorsRegulatory IssuesPatient ComplianceHealthcare EconomicsCompany ProfilesInjectable Antibodies: Products, Markets, Players and Forecasts (From Slideshare) Page 2/5
  3. 3. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Injectable Antibodies: Products, Markets, Players and Forecasts (From Slideshare) Page 3/5
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Injectable Antibodies: Products, Markets, Players and Forecasts Product Formats Please select the product formats and the quantity you require. 1 User License--USD 3 850.00 Quantity: _____ Site License--USD 5 500.00 Quantity: _____ Corporate License--USD 8 500.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Injectable Antibodies: Products, Markets, Players and Forecasts (From Slideshare) Page 4/5
  5. 5. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Injectable Antibodies: Products, Markets, Players and Forecasts (From Slideshare) Page 5/5

×